| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Research Abstract |
Mutation in phosphodiesterase 6 genes(PDE6) causes retinitis pigmentosa(RP). The present study demonstrated that apocynin, a NADPH oxidase inhibitor, and nilvadipine, a Ca^<2+> channel blocker with an anti-oxidant effect, protect against photoreceptor cell death in the nmf363 mouse, which has a mutation in Pda6a, and the nmf137 mouse, which has a mutation in Pde6b, respectively. Therefore, these drugs may be able to use for treatment of RP patients.
|
